6 Vasculitis Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Vasculitis Studies in Boston

NCT00315380Recruiting

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflamma...

Boston, MA700 participantsUniversity of Pennsylvania

View Study Details

NCT06868290Recruiting

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis (GPA) or Microscopic P...

Boston, MA126 participantsNovartis Pharmaceuticals

View Study Details

NCT02939573Recruiting

A Randomized Multicenter Study for Isolated Skin Vasculitis

Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis....

Boston, MA90 participantsUniversity of Pennsylvania

View Study Details

NCT07108387Recruiting

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

This is a multi-center, randomized, open label study that will assess the efficacy and safety of ACTEMRA(R) or one of its FDA-approved biosimilars Tocilizumab (TCZ) maintenance versus withdrawal in Gi...

Boston, MA78 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT03004326Recruiting

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis....

Boston, MA50 participantsPeter Merkel

View Study Details

NCT07388277Recruiting

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

The purpose of this study is to evaluate the safety of CC-97540 in relapsed or refractory severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis....

Boston, MA12 participantsMarcela V. Maus, M.D.,Ph.D.

View Study Details

About Vasculitis Clinical Trials in Boston

Vasculitis refers to a group of disorders that involve inflammation of blood vessels, which can restrict blood flow and damage organs. Types include ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis. Treatment typically involves corticosteroids and immunosuppressive medications.

There are currently 6 vasculitis clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 1,056 participants. Research is being sponsored by University of Pennsylvania, Novartis Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID) and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Vasculitis Clinical Trials in Boston — FAQ

Are there vasculitis clinical trials in Boston?

Yes, there are 6 vasculitis clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What vasculitis treatments are being tested?

The 6 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for vasculitis.

Data updated July 13, 2026 from ClinicalTrials.gov